drugset / Trial / NCT05366738

A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in Healthy Participants

NCT05366738

Phase 1 Completed 27 enrolled Phathom Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of this study is to assess the bioavailability (BA) of a single oral dose of vonoprazan 20 mg sprinkle capsule, either sprinkled on pudding or on applesauce, relative to a vonoprazan 20 mg tablet in healthy participants.

Timeline

Start
2022-05-18
Primary completion
2022-07-01
Completion
2022-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Vonoprazan Other / unclassified 20 mg Oral

Indications

No indication recorded.